Our Team

With over 25 years of experience in corporate finance, Aaron leads ALCOR® Scientific’s financial trajectory as CFO.

Focusing on the in vitro diagnostics market from point of care lateral flow platforms to high volume central laboratory immunochemistry, Aaron has lead finance teams across the spectrum from corporate FP&A to supply chain finance. Whether in a start-up environment or a large-scale international project, Aaron believes deeply in the power of corporate entrepreneurship and developing high performance teams.

Aaron holds an MBA from Babson College and a BS in corporate finance and industrial/organizational psychology from the University of Minnesota. Balanced by a wonderful family, he enjoys all things on the water with family and friends.

Joining ALCOR Scientific in 2009, Alana Worrall initially started in customer service, where she developed a strong foundation in client relations. From there, she transitioned into International Sales, gaining valuable insights into the global market and expanding the company’s reach internationally. After honing her skills in sales and customer engagement, Alana returned to Operations and Logistics, focusing on optimizing order processing, shipping, and warehouse management to enhance the overall customer experience. Today, as Senior Director of Operations, Alana is a key member of ALCOR Scientific’s leadership team.

Anthony DeBellis joined ALCOR® Scientific in March 2022. Anthony has a strong record of leading teams and has 30 years of commercial experience in healthcare. Anthony has held key leadership positions with Luminex, Alere and Abbott where he served as Vice President and global leader of the RALS connectivity business. Anthony brings leadership, strategy development and commercial expertise across numerous segments of diagnostics.

Francesco Frappa has a long history of creating disruptive in vitro diagnostics platforms over the course of his career. He has led the design and development of ALCOR® Scientific’s products for over a decade. While Francesco’s expertise is in hemorheology and immunology, he has a deep understanding of scientific principles used across different sectors of the clinical laboratory market. In addition to his scientific knowledge, he is highly skilled in system design, including photometry, robotics, and software design.​

Jim Post, an Executive Advisor to Water Street Healthcare Partners, was appointed CEO of ALCOR® Scientific in February 2022 and serves on the Board of Directors. Jim has a strong record of leading teams and businesses to drive innovation in healthcare.

As president of the anatomic pathology business for Thermo Fisher Scientific, Jim spearheaded its turnaround, growth and successful sale to global healthcare company PHC Holdings Corporation (PHC). He led the integration of the business into PHC as president and CEO of the newly formed entity, Epredia, where he helped position it as a global leader in precision cancer and tissue diagnostics. Prior to Thermo Fisher, Jim held key management positions with Alere, the world leader in point-of-care and rapid diagnostic devices, including president of its global hospital business.

Jim began his career in the healthcare instrument business with United States Surgical, where he was promoted to positions of increasing responsibility. He is a graduate of the University of Rochester.

Joe Langella joined ALCOR® Scientific as a Mechanical Engineer in early 2013 prior to the launch of the diagnostic business. His responsibilities have evolved over his tenure at the company, ranging from serving as an IVD Manufacturing and Service Technician to establishing the Manufacturing and Repair departments. Before assuming the role of VP of R&D, Joe was the lead mechanical design engineer and focused primarily on new product development, acquiring broad experience in new products’ system design and architecture. Joe is now leading a growing Research and Development department poised to bring new and innovative diagnostic products to market that will continue the company’s tradition of enhancing laboratory efficiency.

A former Medical Technologist, Megan McCutcheon is a product marketing leader with over 20 years of experience in the in vitro diagnostics industry. She has built a dynamic career spanning strategic marketing, global product launches, and business development across multiple small, fast-paced, investor-backed companies. She has successfully led commercial strategies for innovative diagnostic technologies, managed product life cycles, implemented demand generation initiatives, and supported M&A and market expansion efforts. With lab test results influencing the majority of clinical decisions, Megan is a passionate believer in the ability of in vitro diagnostics to transform lives.

Tom Blassey is a 35-year veteran in laboratory diagnostic Sales, Marketing and Distribution. He started his healthcare career with Abbott Diagnostics and worked for some of the largest companies in the industry including Alere Diagnostics, BD and ThermoFisher Scientific.

Tom has extensive experience in distribution, having managed executive relationships in both the acute and non-acute segment of the healthcare market. He has managed Regional and National sales teams and currently manages overseas U.S. Distribution as well as International Distributors in over 40 countries.